TipRanks
Curative Biotechnology (CUBT)
OTHER OTC:CUBT
US Market
CUBT
Curative Biotechnology
RESEARCH TOOLSreports

Curative Biotechnology (CUBT) Income Statement

20 Followers

Curative Biotechnology Income Statement

Last quarter (Q2 2026), Curative Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Curative Biotechnology's net income was $-608.91K. See Curative Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -87.84K$ -92.21K$ -97.52K$ -7.96K$ -6.74K
Operating Expenses
$ 1.41M$ 2.35M$ 1.83M$ 4.44M$ 5.00M
Depreciation and Amortization
$ 87.84K$ 92.21K$ 97.52K$ 99.80K$ 6.74K
EBITDA
$ -1.41M$ -2.35M$ -2.50M$ -4.36M$ -5.16M
Operating Income
$ -1.50M$ -2.44M$ -1.93M$ -4.47M$ -5.01M
Other Income/Expenses
$ -761.01K$ -1.12M$ -2.02M$ -913.57K$ -326.00K
Pretax Income
$ -2.26M$ -3.56M$ -3.96M$ -5.38M$ -5.34M
Net Income
$ -2.26M$ -3.56M$ -3.96M$ -5.38M$ -5.34M
Per Share Metrics
Basic EPS
$ >-0.01$ -0.60$ -1.32$ -1.47$ -5.64
Diluted EPS
$ >-0.01$ -0.60$ -1.32$ -1.44$ -5.64
Weighted Average Shares Outstanding
 1.02B 6.05M 4.41M 3.75M 2.15M
Weighted Average Shares Outstanding (Diluted)
 1.02B 6.05M 4.41M 3.81M 2.15M
Currency in USD

Curative Biotechnology Earnings and Revenue History